CHCHD2
Basic information
Region (hg38): 7:56094567-56106479
Previous symbols: [ "C7orf17" ]
Links
Phenotypes
GenCC
Source:
- Parkinson disease 22, autosomal dominant (Strong), mode of inheritance: AD
- Parkinson disease 22, autosomal dominant (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Parkinson disease 22, autosomal dominant | AD | Neurologic | Response to levodopa has been described | Neurologic | 25662902 |
ClinVar
This is a list of variants' phenotypes submitted to
- Parkinson disease 22, autosomal dominant (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHCHD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 34 | 37 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 11 | 18 | ||||
Total | 1 | 0 | 37 | 16 | 11 |
Variants in CHCHD2
This is a list of pathogenic ClinVar variants found in the CHCHD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-56101726-C-T | Benign (Mar 28, 2021) | |||
7-56101805-T-TA | CHCHD2-related disorder | Benign (Apr 02, 2021) | ||
7-56101870-A-T | Uncertain significance (Oct 01, 2022) | |||
7-56101877-A-G | Likely benign (Jul 08, 2022) | |||
7-56101980-G-GT | Likely benign (Apr 05, 2021) | |||
7-56102754-A-G | Benign (May 11, 2021) | |||
7-56102850-T-C | Likely benign (Dec 02, 2023) | |||
7-56102853-G-A | Benign (Nov 11, 2023) | |||
7-56102878-C-T | Parkinson disease 22, autosomal dominant | Uncertain significance (Sep 08, 2023) | ||
7-56102894-C-T | Amelogenesis imperfecta | Benign (Apr 04, 2019) | ||
7-56102907-C-A | Uncertain significance (Sep 24, 2023) | |||
7-56102913-G-A | CHCHD2-related disorder | Likely benign (Aug 12, 2021) | ||
7-56102918-T-G | not specified | Uncertain significance (Mar 20, 2024) | ||
7-56102921-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
7-56102936-G-A | Uncertain significance (Nov 19, 2023) | |||
7-56102939-C-T | Uncertain significance (Jun 13, 2022) | |||
7-56102951-A-C | Uncertain significance (Dec 27, 2021) | |||
7-56102953-T-C | Uncertain significance (Jun 27, 2022) | |||
7-56102992-G-C | Uncertain significance (Feb 08, 2018) | |||
7-56103000-T-TC | Uncertain significance (Jul 07, 2023) | |||
7-56104067-A-C | Benign (Apr 05, 2021) | |||
7-56104219-T-G | Likely benign (Jul 23, 2021) | |||
7-56104221-C-T | Parkinson disease 22, autosomal dominant | Pathogenic (Jul 01, 2015) | ||
7-56104230-T-C | Uncertain significance (Jan 06, 2024) | |||
7-56104233-G-A | Uncertain significance (Dec 23, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHCHD2 | protein_coding | protein_coding | ENST00000395422 | 4 | 5008 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.73e-7 | 0.0725 | 125732 | 0 | 15 | 125747 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.121 | 88 | 91.3 | 0.964 | 0.00000484 | 950 |
Missense in Polyphen | 14 | 20.725 | 0.67553 | 265 | ||
Synonymous | 0.468 | 32 | 35.5 | 0.900 | 0.00000202 | 329 |
Loss of Function | -0.855 | 9 | 6.63 | 1.36 | 2.88e-7 | 67 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000793 | 0.0000791 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor. Binds to the oxygen responsive element of COX4I2 and activates its transcription under hypoxia conditions (4% oxygen), as well as normoxia conditions (20% oxygen) (PubMed:23303788). {ECO:0000269|PubMed:23303788}.;
- Disease
- DISEASE: Parkinson disease 22 (PARK22) [MIM:616710]: An autosomal dominant form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:25662902}. Note=The gene represented in this entry may be involved in disease pathogenesis.;
- Pathway
- Metabolism of proteins;Mitochondrial protein import
(Consensus)
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- loftool
- 0.686
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.54
Haploinsufficiency Scores
- pHI
- 0.0157
- hipred
- N
- hipred_score
- 0.255
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.942
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chchd2
- Phenotype
Gene ontology
- Biological process
- mitochondrion organization;positive regulation of transcription by RNA polymerase II;regulation of cellular response to hypoxia
- Cellular component
- nucleus;mitochondrion;mitochondrial intermembrane space
- Molecular function
- protein binding;transcription factor binding;sequence-specific DNA binding